• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    8i Acquisition 2 Corp. Announces Approval of Business Combination and Ability of Shareholders to Withdraw Ordinary Shares Tendered for Redemption

    11/10/22 4:01:00 PM ET
    $LAX
    Get the next $LAX alert in real time by email

    Singapore, Nov. 10, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (NASDAQ:LAX, the "Company"))), a special purpose acquisition company, announced today that all proposals presented to shareholders at the special meeting of shareholders held on November 10, 2022 at 10:00 a.m. Eastern Time relating to the Company's business combination with EUDA Health Limited were approved by shareholders. Holders of Company's ordinary shares that elected to redeem shares in connection with the Company's special meeting of shareholders may withdraw such redemption requests by no later than 5:00 p.m. Eastern Time on November 11, 2022. Based on a total of 8,195,770 ordinary shares tendered for redemption in connection the special meeting of shareholders as of 5 p.m. on November 8, 2022, the final redemption price is $10.0837 per share redeemed.

    About 8i Acquisition 2 Corp.

    8i Acquisition 2 Corp. is a British Virgin Islands company incorporated in January 2021 as a blank check company for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. LAX's efforts to identify a prospective target business will not be limited to a particular industry or geographic region, although LAX intends to focus on targets located in Asia.

    Forward-Looking Statements

    This press release includes forward-looking statements that involve risks and uncertainties. Forward looking statements are statements that are not historical facts. Such forward-looking statements, including the successful consummation of the Company's initial public offering, are subject to risks and uncertainties, which could cause actual results to differ from the forward looking statements. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.

    For investor and media inquiries, please contact:

    Gateway Group

    IR: Cody Slach or Matthew Hausch

    PR: Zach Kadletz

    Phone: (949) 574-3860

    E-mail : [email protected]



    Primary Logo

    Get the next $LAX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LAX

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LAX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    8i Acquisition 2 Corp. and EUDA Health Ltd Complete Business Combination

    Singapore, Nov. 23, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (the "Company" or "LAX") (NASDAQ:LAX), a publicly traded special purpose acquisition company, today announced the completion of its business combination (the "Business Combination") with EUDA Health Ltd ("EUDA Health"), a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering improved outcomes through personalized healthcare. The combined company will operate under the name "EUDA Health Holdings Limited" (NASDAQ:EUDA) and will be led by Founder and Chief Executive Officer Dr. Kelvin Chen. Commencing at the open of trading on N

    11/23/22 4:32:15 PM ET
    $LAX

    8i Acquisition 2 Corp. and EUDA Health Limited Complete Business Combination

    Singapore, Nov. 17, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (the "Company" or "LAX") (NASDAQ:LAX), a publicly traded special purpose acquisition company, today announced the completion of its business combination (the "Business Combination") with EUDA Health Limited ("EUDA Health"), a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering improved outcomes through personalized healthcare. The combined company will operate under the name "EUDA Health Holdings Limited" and will be led by Founder and Chief Executive Officer Dr. Kelvin Chen. Commencing at the open of trading on November 18, 202

    11/17/22 5:23:47 PM ET
    $LAX

    8i Acquisition 2 Corp. Announces Approval of Business Combination and Ability of Shareholders to Withdraw Ordinary Shares Tendered for Redemption

    Singapore, Nov. 10, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (NASDAQ:LAX, the "Company"))), a special purpose acquisition company, announced today that all proposals presented to shareholders at the special meeting of shareholders held on November 10, 2022 at 10:00 a.m. Eastern Time relating to the Company's business combination with EUDA Health Limited were approved by shareholders. Holders of Company's ordinary shares that elected to redeem shares in connection with the Company's special meeting of shareholders may withdraw such redemption requests by no later than 5:00 p.m. Eastern Time on November 11, 2022. Based on a total of 8,195,770 ordinary shares tendered for redemption in

    11/10/22 4:01:00 PM ET
    $LAX

    $LAX
    SEC Filings

    View All

    SEC Form 6-K filed by 8i Acquisition 2 Corp.

    6-K - EUDA Health Holdings Ltd (0001847846) (Filer)

    1/22/24 9:30:30 PM ET
    $LAX

    SEC Form 6-K filed by 8i Acquisition 2 Corp.

    6-K - EUDA Health Holdings Ltd (0001847846) (Filer)

    1/17/24 6:10:06 AM ET
    $LAX

    SEC Form 6-K filed by 8i Acquisition 2 Corp.

    6-K - EUDA Health Holdings Ltd (0001847846) (Filer)

    12/29/23 5:03:20 PM ET
    $LAX

    $LAX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chen Wei Wen Kelvin

    4 - EUDA Health Holdings Ltd (0001847846) (Issuer)

    6/20/23 3:19:26 PM ET
    $LAX

    SEC Form 3: New insider Wong Kongyew claimed no ownership of stock in the company

    3 - EUDA Health Holdings Ltd (0001847846) (Issuer)

    6/8/23 8:31:59 PM ET
    $LAX

    SEC Form 4 filed by Chen Wei Wen Kelvin

    4 - EUDA Health Holdings Ltd (0001847846) (Issuer)

    5/26/23 8:42:17 AM ET
    $LAX

    $LAX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by 8i Acquisition 2 Corp. (Amendment)

    SC 13D/A - EUDA Health Holdings Ltd (0001847846) (Subject)

    5/26/23 8:44:16 AM ET
    $LAX

    SEC Form SC 13G/A filed by 8i Acquisition 2 Corp. (Amendment)

    SC 13G/A - EUDA Health Holdings Ltd (0001847846) (Subject)

    2/14/23 10:13:57 AM ET
    $LAX

    SEC Form SC 13G/A filed by 8i Acquisition 2 Corp. (Amendment)

    SC 13G/A - EUDA Health Holdings Ltd (0001847846) (Subject)

    2/7/23 4:59:19 PM ET
    $LAX